Mo. ° / °
    Ariz. ° / °
    Calif. ° / °
ATSU Continuing Education

march, 2022

23mar7:30 am12:00 pm2022 DO-Touch.NET Annual Meeting & Educational Seminar2022 DO-Touch.NET Annual Meeting & Educational Seminar


Event Details

2022 DO-Touch.NET Annual Meeting and Educational Seminar

Let’s DO OMM Research!

Mar. 23, 2022 | 7:30 a.m. – 12:00 p.m. (EST)

Click MORE for activity information and tuition pricing.


*4 AOA Category 1-A Credits

  • Non-member: $100
  • Active Member: Free (with discount code)
    *Those who have participated in DO-Touch.NET programming (e.g., Let’s Talk About OMM Research!) during 2021.
  • Member: $50 (with discount code)
    *Those who have completed a membership form prior to February 1, 2022, but have not participated in DO-Touch.NET programming during 2021.

REGISTRATION EXTENDED: Mar. 16, 2022 at 5:00 PM (CST).


Mark your calendars and plan to attend!


Brian Degenhardt, DO, C-NMM/OMM

This activity will provide attendees the ability to better understand the purpose and value of using patient-reported outcomes (PROs) in their clinical practice and learn models of how to integrate PROs into their clinical practice; improve their precision in using of OMT technique nomenclature both within their practice and when participating in research related to OMT; and evaluate methods for assessing the effectiveness and safety of OMT to treat post-COVID syndrome.


  • Employ patient-reported outcomes in their clinical practice to improve the quality of patient care
  • Apply classification schemes for osteopathic manipulative treatment (OMT) techniques to improve the precision and reproducibility of the labeling of techniques being used in the clinic
  • Explain how OMT affects patients with post-COVID syndrome.

OMM Practitioners

At previous annual meetings and monthly seminars, we have worked to develop a culture of research with osteopathic physicians who routinely perform osteopathic manipulation in their practice, i.e. DO-Touch.NET members. This gap is present in most, if not all, practice specialties within the osteopathic profession. Over the past several years, we have been working on exposing members to patient-reported outcomes and their value in clinical practice. Establishing a system and integrating it into individual practice environments remains a major hurdle in advancing osteopathic manipulative medicine practice and research within this field.

Current practice habits and educational activities have not been able to advance traditional osteopathic manipulative medicine practice into a 21st century model that utilizes the latest tools to evaluate the effectiveness of medical care.

To progressively address the practice gaps outlined above, participants will learn how PROs can be implemented into clinical practice, report on how PROs could be integrated into their practices, expand on understanding the value of using such measures, improve current data reporting in medical records, and learn about unfolding studies being sponsored by the network that they can participate in.


A.T. Still University (ATSU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.

ATSU designates this activity for a maximum of 4 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

Call the ATSU CE Office at 660-626-2232 for more information.

Evidence-Based Content: It is the policy of the ATSU to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

ATSU Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, CESC, presenters, faculty, authors) participating in an educational activity provided by the ATSU are required to disclose to the provider any relevant financial relationships with any commercial interest. ATSU must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Disclosure Statement: It is the policy of the ATSU Continuing Education Department to ensure balance, independence, objectivity and scientific rigor in all its educational activities.  Faculty disclosures will be made in the syllabus and/or during faculty introductions.  The audience is advised that one or more presentations in this continuing education activity may contain references of unlabeled or unapproved uses of drugs or devices.

Resolution/Mechanism of Identified Conflict of Interest: Independent sources of review include the following: All disclosures will be reviewed by the activity directors, CE Assistant Vice President, or CE Director for identification of conflicts of interest. Reviewers, working with the activity directors will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the activity director
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty-The reviewer should be a physician or other scientist with knowledge of the specialty area being reviewed and often times the Assistant Vice President of Continuing Education will perform this first review and can then appoint an independent reviewer.-The independent reviewer is not be involved in the planning of this CME Activity and cannot have a relationship with any corporate entity supporting the CME activity.-The reviewer should have a copy of this policy and a copy of the Standards for Commercial Support to fully grasp their responsibilities as the reviewer. Off-Label or Unapproved Use of Drugs or Devices

It is the policy of the ATSU to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by the presenters and planners of educational content in this activity are their own and do not necessarily represent the viewpoint of the ATSU.

Consent to Use of Photographic Images: Registration and attendance at or participation in ATSU meetings and other activities constitutes an agreement by the registrant to ATSU’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside ATSU meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this ATSU activity is prohibited without the written permission from individual authors and ATSU.

Special Assistance: ATSU complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the CE staff at the registration desk or call 660-626-2232 for assistance.


(Wednesday) 7:30 am - 12:00 pm


DO-Touch.NETSara Amini-Rad, MPH, CHES | 660.626.2101 |

Comments are closed.